Cara Therapeutics reported $665K in Interest Income for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Interest Income Change
Aerie Pharmaceuticals AERI:US USD 542K 285K
Cara Therapeutics CARA:US USD 665K 399K
Endo International ENDP:US USD 178K 31K
Jazz Pharmaceuticals JAZZ:US USD 3.5M 2.8M
Pacira PCRX:US USD 1.23M 982K
Pain Therapeutics PTIE:US USD 878K 564K
Pfizer PFE:US USD 70M 40M
Revance Therapeutics RVNC:US USD 1.16M 546K
Supernus Pharmaceuticals SUPN:US USD 2.8M 1.01M